I will be publishing an article explaining in more detail, in the meantime, here is the basic information.
The pdf that Citron linked to is a 'Pharmacy Directory Listing' (PDL). This is a Member document. The document was also an update, to the actual PDL, that members receive.
UNH has been covering Acthar for a few years, and this Member document was never updated to include Acthar.
The update pdf, specifically states that it will be mailed to members. The front end UNH website states these documents are not for coverage determination but rather education and training purposes.
UNH's Coverage Policy has not changed. It is still the same as it was when I checked last night.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha
community. Instablog posts are not selected, edited or screened by Seeking Alpha editors,
in contrast to contributors' articles.
Well, whoever sold today are responsible for their loses. Why investors should listen to a short seller that has only one motive and that is bring the share price down. Again, I see desperation here by citron as they are publishing anything they could find now to bring the share price down.
"Citron Research is a one-man show run by Mr. Andrew Left, whose fraudulent career began with a huge black mark. In 1998, in his first job, Mr. Left was found by the National Futures Association to have: “MADE FALSE AND MISLEADING STATEMENTS TO CHEAT, DEFRAUD OR DECEIVE A CUSTOMER IN VIOLATION OF NFA COMPLIANCE RULES 2-2(a) AND 2-29(a)(1). ” Mr. Left was debarred for three years, among other punishments. This finding can be found on the website of the National Futures Association."
Why does anyone keep listening to a trickster like Citron---the Loki of "analysts".
His skill lay in cherry picking facts and leading a reader to a conclusion with National Enquirer types of tactics. Bold red capital letters for half conclusions, Ending paragraphs with a 'what should an investor' think question, and stating strongly stated 'opinions' of the future.
Without providing full resources for the reader to quickly research, and with willing participants in a bear raid, due to the uptick rule no longer existing, it is easy for investors to panic. By the time they do their own research, they could be wiped out, IF and this is important IF it was all true.
If any readers really don't like this occurring in the market, I recommend becoming active in lobbying the SEC to reinstate the uptick rule. It helps more than it harms.
Good to hear the UNH care assessment from a person in the business - you are right, simple investors like me can not fact check that quickly and QCOR is now the most volatile stock of S&P500! When the stock dropped like a stone yesterday I felt very uneasy - but I bought the dip! This CAN go bad though. Buying the dip the first time in QCOR was a bad idea while the second time was fine........I bought them all........
Mike, as always you are on top of the info heap and bringing about a clear and honest assessment of situations relative to QCOR. Mr Left (Citron) has been convicted on financial fraud in the past. Complete agreement that the uptick rule needs to be reinstated. With a reputable firm like Deerfield Management coming into QCOR with a 5.8% stake this only reaffirms QCOR as a company having tremendous benefits to their patient base, retaining continued growth opportunity. Long and strong QCOR.
It's funny how Citron implied that Qcor was suspiciously holding something back because they had not notified their shareholders about this change. We all know this is laughable because when you add up all of the different insurance companies policy changes they are probably happening every day. When you deal with high cost drugs you prepare yourself or your physicians to deal with insurance issues everyday. It is part of the cost of doing business. It protects the insurance company and the patient. It is part of the status quo in the insurance business.
Yes, I'm sure every Pharma company has hired someone to monitor all the different Insurance company's websites... for any change whatsoever... on every single webpage, pdf, etc. including documentation that goes to members, and has nothing to do with a coverage change.
Citron is really going out on a limb, with credibility, implying such a thing. Sure did sound good though... just like "Alien Abductions" in the National Enquirer, at the grocery checkout. You know it's not true, but you read it anyways, admit it, you do. LOL
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
Questcor's New Attack By Citron 11 comments
I will be publishing an article explaining in more detail, in the meantime, here is the basic information.
The pdf that Citron linked to is a 'Pharmacy Directory Listing' (PDL). This is a Member document. The document was also an update, to the actual PDL, that members receive.
UNH has been covering Acthar for a few years, and this Member document was never updated to include Acthar.
The update pdf, specifically states that it will be mailed to members. The front end UNH website states these documents are not for coverage determination but rather education and training purposes.
UNH's Coverage Policy has not changed. It is still the same as it was when I checked last night.
Questcor (QCOR), is still on target for earning.
Disclosure: I am long QCOR.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
Share this Instablog
This post has 11 comments:
"Citron Research is a one-man show run by Mr. Andrew Left, whose fraudulent career began with a huge black mark. In 1998, in his first job, Mr. Left was found by the National Futures Association to have: “MADE FALSE AND MISLEADING STATEMENTS TO CHEAT, DEFRAUD OR DECEIVE A CUSTOMER IN VIOLATION OF NFA COMPLIANCE RULES 2-2(a) AND 2-29(a)(1). ” Mr. Left was debarred for three years, among other punishments. This finding can be found on the website of the National Futures Association."
Why does anyone keep listening to a trickster like Citron---the Loki of "analysts".
Without providing full resources for the reader to quickly research, and with willing participants in a bear raid, due to the uptick rule no longer existing, it is easy for investors to panic. By the time they do their own research, they could be wiped out, IF and this is important IF it was all true.
If any readers really don't like this occurring in the market, I recommend becoming active in lobbying the SEC to reinstate the uptick rule. It helps more than it harms.
Citron is really going out on a limb, with credibility, implying such a thing. Sure did sound good though... just like "Alien Abductions" in the National Enquirer, at the grocery checkout. You know it's not true, but you read it anyways, admit it, you do. LOL
Latest Followers
StockTalks
-
Kaiser Georgia adds Acthar to formulary $QCOR http://bit.ly/XxDzNX
Feb 11, 2013
-
BlockRock buy $QCOR (8% ownership) and $KERX (5% ownership) per SEC filings last week and this morning.
Feb 11, 2013
-
http://seekingalpha.com/p/pdyt explanation of Citron's attack
Oct 17, 2012
More »Latest Comments
Most Commented
Posts by Themes